DexCom (DXCM) Earnings Date, Estimates & Call Transcripts $71.02 -0.28 (-0.39%) As of 03:45 PM Eastern Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock DexCom Earnings Summary Upcoming Earnings DateMay. 1Before Market OpensEstimatedConsensus EPS (Feb. 13) $0.50 Actual EPS (Feb. 13) $0.45 Missed By -$0.05 DexCom announced Q4 2024 earnings on February 13, 2025, reporting an EPS of $0.45, which missed analysts' consensus estimates of $0.50 by $0.05. With a trailing EPS of $1.43 and a P/E Ratio of 49.66, DexCom's earnings are expected to grow 21.18% next year, from $2.03 to $2.46 per share. Q4 2024 Earnings ResourcesQ4 2024 Earnings ReportConference Call Transcript & Audio Slide Deck Press Release (8-K) Annual Report (10-K)DXCM Upcoming EarningsDexCom's Q1 2025 earnings is scheduled for Thursday, May 1, 2025, with a conference call scheduled at 7:00 AM ET. Check back for transcripts, audio, and key financial metrics as they become available.Q1 2025 Earnings ReportSlide DeckFull Screen Slide DeckPowered by Get DexCom Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on DexCom and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataDXCM Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.DXCM Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. DexCom Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20253$0.31$0.37$0.34Q2 20253$0.47$0.51$0.48Q3 20252$0.58$0.59$0.59Q4 20252$0.64$0.66$0.65FY 202510$2.00$2.13$2.06Q1 20261$0.44$0.44$0.44Q2 20261$0.58$0.58$0.58Q3 20261$0.69$0.69$0.69Q4 20261$0.72$0.72$0.72FY 20264$2.43$2.43$2.43 DexCom Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 5/1/2025(Estimated)-------2/13/2025Q4 2024$0.50$0.45 -$0.05$0.38$1.10B-7/25/2024Q2 2024$0.39$0.43+$0.04$0.51$1.04B$1.00B4/25/2024Q1 2024$0.27$0.32+$0.05$0.28$911.20M$921.00M2/8/2024Q4 2023$0.43$0.50+$0.07$0.38$1.02B$1.03B10/26/2023Q3 2023$0.34$0.50+$0.16$0.71$939.64M$975.00M7/27/2023Q2 2023$0.22$0.34+$0.12$0.40$841.16M$871.30M DexCom Earnings - Frequently Asked Questions When is DexCom's earnings date? DexCom has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, May 1st, 2025 based off last year's report dates. Learn more on DXCM's earnings history. What guidance has DexCom issued on next quarter's earnings? DexCom updated its FY 2025 earnings guidance on Tuesday, March, 4th. The company issued revenue guidance of $4.6 billion-$4.6 billion, compared to the consensus revenue estimate of $4.6 billion. Did DexCom beat their earnings estimates last quarter? In the previous quarter, DexCom (NASDAQ:DXCM) missed the analysts' consensus estimate of $0.50 by $0.05 with a reported earnings per share (EPS) of $0.45. Learn more on analysts' earnings estimate vs. DXCM's actual earnings. How can I listen to DexCom's earnings conference call? The conference call for DexCom's latest earnings report can be listened to online. Listen to Conference Call How can I read DexCom's conference call transcript? The conference call transcript for DexCom's latest earnings report can be read online. Read Transcript How much revenue does DexCom generate each year? DexCom (NASDAQ:DXCM) has a recorded annual revenue of $4.03 billion. How much profit does DexCom generate each year? DexCom (NASDAQ:DXCM) has a recorded net income of $576.20 million. DXCM has generated $1.43 earnings per share over the last four quarters. What is DexCom's price-to-earnings ratio? DexCom (NASDAQ:DXCM) has a trailing price-to-earnings ratio of 49.56 and a forward price-to-earnings ratio of 34.91. The price/earnings-to-growth ratio is 2.3. What is DexCom's EPS forecast for next year? DexCom's earnings are expected to grow from $2.03 per share to $2.46 per share in the next year, which is a 21.18% increase. More Earnings Resources from MarketBeat Related Companies Medtronic Earnings Results Becton, Dickinson and Company Earnings Results Edwards Lifesciences Earnings Results IDEXX Laboratories Earnings Results ResMed Earnings Results STERIS Earnings Results Insulet Earnings Results Baxter International Earnings Results Hologic Earnings Results Globus Medical Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Amazon's Earnings Will Make or Break the Stock's Comeback CrowdStrike Stock Nears Record High, Dip Ahead of Earnings?Alphabet Rebounds After Strong Earnings and Buyback AnnouncementMarkets Think Robinhood Earnings Could Send the Stock UpIs the Floor in for Lam Research After Bullish Earnings?Texas Instruments: Earnings Beat, Upbeat Guidance Fuel RecoveryMarket Anticipation Builds: Joby Stock Climbs Ahead of Earnings This page (NASDAQ:DXCM) was last updated on 4/30/2025 by MarketBeat.com Staff From Our PartnersM.A.G.A. is Finished – This Could be even BetterYou’ve no doubt heard Trump’s rally cry: Make America Great Again. But recently the President made a big ch...Paradigm Press | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredDOGE officially begins retirement transformationElon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retireme...Altimetry | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredHere’s How to Claim Your Stake in Elon’s Private Company, xAII predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredMusk's warning signal: Prepare before the cascade beginsWhen Elon Musk triggered his AI layoff plan, most analysts missed what it really meant. Louis Navellier didn’t...InvestorPlace | SponsoredThe collapse has already startedThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding DexCom, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share DexCom With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy DXCM Stock Free DXCM Stock Alerts